UNSPSC 51173201: Bisacodyl/magnesium citrate/phenolphthalein

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA209. This VA Drug Class (GA209) classifies this compound as belonging to the group LAXATIVES, OTHER.

UNSPSC 51173201 Bisacodyl/magnesium citrate/phenolphthalein is a Commodity code that nominally covers specific laxative and cathartic active pharmaceutical ingredients, though recent state and local activity shows limited direct solicitation under this code. The three recent opportunities posted mention the code in connection with broader pharmaceutical and drug-testing procurement — an offender specimen collection and drug testing RFP from Collin County, Texas; a Therapeutic Pharmacy Initiative information-gathering RFI from the Texas Health and Human Services Commission; and a generic multi-source pharmaceuticals and OTC products cooperative purchasing RFP from the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) — but none of these solicitations specifically name bisacodyl, magnesium citrate, or phenolphthalein formulations as a line item or deliverable. The issuing bodies span county criminal-justice supervision, state health and human services agencies, and multi-state cooperative purchasing vehicles.

The geographic concentration appears limited to Texas and Minnesota based on the recent-opportunity record; no other states show activity under this code in the available sources. The Collin County RFP for offender specimen collection and drug testing (RFP 2026-327, due July 23, 2026, with estimated contract value of $600,000) focuses on immunoassay screening and confirmatory testing services rather than pharmaceutical ingredients. The Texas HHS RFI (HHS0017013, posted April 3, 2026) addresses direct-to-manufacturer prescription programs and pharmacy benefit management, an exploratory procurement seeking vendor capabilities rather than a buy of specific products. The MMCAP RFP (S1070000015802, due March 26, 2026) solicits generic multi-source pharmaceuticals and OTC products across authorized wholesalers but does not identify bisacodyl, magnesium citrate, or phenolphthalein as specifically named products in the available summary. The code shows little recent activity directly aligned with its nominal scope, and the recent opportunities tagged under it are more accurately characterized as addressing drug testing services, pharmacy benefit administration, and broad pharmaceutical procurement rather than specific cathartic ingredients.